Ainos Inc (AIMD)
$0.49
Performance
- $0.49$0.54$0.49
0.0%
Downside
Day's Volatility :9.26%
Upside
9.26%
- $0.45$4.29$0.49
7.96%
Downside
52 Weeks Volatility :89.49%
Upside
88.58%
Returns
| Period | Ainos Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -37.21% | 0.0% |
6 Months | -53.85% | 0.0% |
1 Year | -82.0% | 0.0% |
3 Years | -99.14% | -20.1% |
Highlights
Market Capitalization | 4.0M |
Book Value | $2.8 |
Earnings Per Share (EPS) | -3.21 |
Profit Margin | 0.0% |
Operating Margin TTM | -21895.96% |
Return On Assets TTM | -25.61% |
Return On Equity TTM | -60.31% |
Revenue TTM | 65.1K |
Revenue Per Share TTM | 0.01 |
Quarterly Revenue Growth YOY | -57.8% |
Gross Profit TTM | 410.4K |
EBITDA | -9.4M |
Diluted Eps TTM | -3.21 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Ainos Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Ainos Inc | -1.62% | -53.85% | -82.0% | -99.14% | -99.14% |
 Stryker Corporation | -2.04% | 0.53% | 32.26% | 33.33% | 65.12% |
 Boston Scientific Corp. | 2.72% | 22.03% | 60.82% | 95.57% | 107.73% |
 Edwards Lifesciences Corp. | -2.16% | -29.21% | -11.3% | -40.29% | -12.91% |
 Abbott Laboratories | -1.43% | 1.55% | 15.84% | -3.66% | 38.49% |
 Medtronic Plc | -2.36% | 5.86% | 15.3% | -30.39% | -18.17% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Ainos Inc | NA | NA | NA | 0.0 | -0.6 | -0.26 | NA | 2.8 |
Stryker Corporation | 39.2 | 39.2 | 2.58 | 12.0 | 0.19 | 0.07 | 0.01 | 51.86 |
Boston Scientific Corp. | 68.15 | 68.15 | 2.06 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
Edwards Lifesciences Corp. | 25.74 | 25.74 | 3.44 | 2.62 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 35.52 | 35.52 | 4.1 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
Medtronic Plc | 30.31 | 30.31 | 1.67 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Ainos Inc | NA | $4.0M | -99.14% | NA | 0.0% |
Stryker Corporation | Buy | $135.3B | 65.12% | 39.2 | 16.12% |
Boston Scientific Corp. | Buy | $124.4B | 107.73% | 68.15 | 12.0% |
Edwards Lifesciences Corp. | Buy | $39.4B | -12.91% | 25.74 | 23.74% |
Abbott Laboratories | Buy | $195.3B | 38.49% | 35.52 | 13.65% |
Medtronic Plc | Buy | $115.5B | -18.17% | 30.31 | 12.06% |
Insights on Ainos Inc
Increasing Revenue
Revenue is up for the last 2 quarters, 19.90K → 20.72K (in $), with an average increase of 4.0% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -5.92M → -3.19M (in $), with an average increase of 41.2% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 60.8% return, outperforming this stock by 142.8%
Institutional Holdings
TWO SIGMA SECURITIES, LLC
0.26%Geode Capital Management, LLC
0.25%BlackRock Inc
0.19%Virtu Financial LLC
0.16%Tower Research Capital LLC
0.11%UBS Group AG
0.10%
Company Information
Organization | Ainos Inc |
Employees | 46 |
CEO | Mr. Chun-Hsien Tsai |
Industry | Miscellaneous |
Discover More
Generation Income Properties Inc
$0.49
-8.7%
Touchstone Climate Transition Etf
$0.49
-8.7%
Atlas Lithium Corp
$0.49
-8.7%
Flexshares Quality Dividend
$0.49
-8.7%
Blackrock New York Muni Inc
$0.49
-8.7%
Timothy Plan International Etf
$0.49
-8.7%
Alger 35 Etf
$0.49
-8.7%
Aadi Bioscience Inc
$0.49
-8.7%
Goldman Sachs Access Inflati
$0.49
-8.7%